Updated consensus statement on biological agents, specifically tumour necrosis factor alpha (TNFalpha) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2004.

D.E. Furst; F.C. Breedveld; J.R. Kalden; J.S. Smolen; G.-R. Burmester; J.W.J. Bijlsma; M. Dougados; P. Emery; E.C. Keystone; L. Klareskog; P.J. mease

Updated consensus statement on biological agents, specifically tumour necrosis factor alpha (TNFalpha) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2004.

Translated title of the contribution: Updated consensus statement on biological agents, specifically tumour necrosis factor alpha (TNFalpha) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2004.

D.E. Furst
, F.C. Breedveld
, J.R. Kalden
, J.S. Smolen
, G.-R. Burmester
, J.W.J. Bijlsma
, M. Dougados
, P. Emery
, E.C. Keystone
, L. Klareskog
, P.J. mease

Rheumatology & Clinical Immunology

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Updated consensus statement on biological agents, specifically tumour necrosis factor alpha (TNFalpha) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2004.
Original language	Undefined/Unknown
Pages (from-to)	ii2-ii12
Number of pages	10
Journal	Annals of the Rheumatic Diseases
Volume	63
Issue number	suppl 2
Publication status	Published - 2004

Cite this

Furst, D. E., Breedveld, F. C., Kalden, J. R., Smolen, J. S., Burmester, G.-R., Bijlsma, J. W. J., Dougados, M., Emery, P., Keystone, E. C., Klareskog, L., & mease, P. J. (2004). Updated consensus statement on biological agents, specifically tumour necrosis factor alpha (TNFalpha) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2004. Annals of the Rheumatic Diseases, 63(suppl 2), ii2-ii12.

@article{89e72e36b9974bd8a516d215bb8636df,

title = "Updated consensus statement on biological agents, specifically tumour necrosis factor alpha (TNFalpha) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2004.",

author = "D.E. Furst and F.C. Breedveld and J.R. Kalden and J.S. Smolen and G.-R. Burmester and J.W.J. Bijlsma and M. Dougados and P. Emery and E.C. Keystone and L. Klareskog and P.J. mease",

year = "2004",

language = "Undefined/Unknown",

volume = "63",

pages = "ii2--ii12",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "Elsevier",

number = "suppl 2",

}

Furst, DE, Breedveld, FC, Kalden, JR, Smolen, JS, Burmester, G-R, Bijlsma, JWJ, Dougados, M, Emery, P, Keystone, EC, Klareskog, L & mease, PJ 2004, 'Updated consensus statement on biological agents, specifically tumour necrosis factor alpha (TNFalpha) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2004.', Annals of the Rheumatic Diseases, vol. 63, no. suppl 2, pp. ii2-ii12.

Updated consensus statement on biological agents, specifically tumour necrosis factor alpha (TNFalpha) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2004. / Furst, D.E.; Breedveld, F.C.; Kalden, J.R. et al.
In: Annals of the Rheumatic Diseases, Vol. 63, No. suppl 2, 2004, p. ii2-ii12.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Updated consensus statement on biological agents, specifically tumour necrosis factor alpha (TNFalpha) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2004.

AU - Furst, D.E.

AU - Breedveld, F.C.

AU - Kalden, J.R.

AU - Smolen, J.S.

AU - Burmester, G.-R.

AU - Bijlsma, J.W.J.

AU - Dougados, M.

AU - Emery, P.

AU - Keystone, E.C.

AU - Klareskog, L.

AU - mease, P.J.

PY - 2004

Y1 - 2004

M3 - Article

SN - 0003-4967

VL - 63

SP - ii2-ii12

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

IS - suppl 2

ER -